Neuland Laboratories Limited (BOM:524558)

India · Delayed Price · Currency is INR

15,208

-94 (-0.61%)

At close: Apr 20, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Manufacture and Sale of Active Pharmaceutical Ingredients and Allied Services	14.77B	15.59B	11.91B	9.52B	9.37B
Manufacture and Sale of Active Pharmaceutical Ingredients and Allied Services Growth	-5.24%	30.81%	25.20%	1.57%	22.64%
Total	14.77B	15.59B	11.91B	9.52B	9.37B
Total Growth	-5.24%	30.81%	25.20%	1.57%	22.64%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	4.36B	2.96B	3.21B	2.39B	2.18B
India Growth	47.43%	-7.79%	34.08%	9.62%	-14.07%
Europe	4.28B	4.62B	3.60B	2.68B	3.30B
Europe Growth	-7.38%	28.43%	34.28%	-18.79%	37.19%
Usa and North America	4.21B	5.99B	3.65B	-	-
Usa and North America Growth	-29.75%	63.96%	-	-	-
Rest of The World	1.49B	1.58B	1.45B	1.63B	1.76B
Rest of The World Growth	-5.77%	9.16%	-10.86%	-7.42%	15.27%
North America	-	-	-	2.53B	-
USA	-	-	-	-	1.94B
USA Growth	-	-	-	-	67.76%
Total	14.34B	15.16B	11.91B	9.23B	9.18B
Total Growth	-5.36%	27.24%	29.01%	0.56%	20.38%

Source: S&P Global Market Intelligence.